Harvard Bioscience, Inc. (HBIO) has fallen -5.05% in a Week, Should You Hold?

A rating of 81 puts Harvard Bioscience, Inc. (HBIO) near the top of the Medical Instruments & Supplies industry according to InvestorsObserver. Harvard Bioscience, Inc.'s score of 81 means it scores higher than 81% of stocks in the industry. Harvard Bioscience, Inc. also received an overall rating of 56, putting it above 56% of all stocks. Medical Instruments & Supplies is ranked 82 out of the 148 industries.

HBIO has an Overall Score of 56. Find out what this means to you and get the rest of the rankings on HBIO!

See Full HBIO Report

What do These Ratings Mean?

Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as “good” for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 56 means the stock is more attractive than 56 percent of stocks. These scores are not only easy to understand, but it is easy to compare stocks to each other. You can find the best stock in an industry, or look for the sector that has the highest average score. The overall score is a combination of technical and fundamental factors that serves as a good starting point when analyzing a stock. Traders and investors with different goals may have different goals and will want to consider other factors than just the headline number before making any investment decisions.

What's Happening With Harvard Bioscience, Inc. Stock Today?

Harvard Bioscience, Inc. (HBIO) stock is trading at $4.14 as of 9:36 AM on Monday, Mar 18, an increase of $0.09, or 2.22% from the previous closing price of $4.05. The stock has traded between $3.99 and $4.14 so far today. Volume today is below average. So far 300 shares have traded compared to average volume of 78,921 shares. Click Here to get the full Stock Report for Harvard Bioscience, Inc. stock.